STOCK TITAN

Logos Global Files Amendment to Schedule 13G for Annexon Showing 0% Stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Annexon, Inc. Schedule 13G/A (Amendment No. 1) discloses that Logos Global entities and William Arsani filed jointly regarding Annexon common stock (CUSIP 03589W102) related to a reportable event dated 06/30/2025. The filing identifies five reporting persons: Logos Global Management LP, Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC, and Arsani William, and provides the filer address at One Letterman Drive, Building C, Suite C3-350, San Francisco, CA 94129.

The statement states each reporting person beneficially owns 0 shares representing 0% of the class, with zero sole or shared voting or dispositive power. The reporting persons say they file jointly but disclaim membership in a group and disclaim beneficial ownership except to the extent of any pecuniary interest. The filing is signed by Arsani William on 08/13/2025.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: This Schedule 13G/A reports no beneficial ownership by Logos Global parties in Annexon, so no change in ownership stake is disclosed.

The filing is procedural and reports 0 shares (0%) beneficially owned by Logos Global Management LP, Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC, and Arsani William. The report clarifies organizational relationships and expressly disclaims group status and beneficial ownership beyond pecuniary interest. For investors, this filing does not indicate an active stake or influence attempt; it documents ownership status and adviser/fund relationships.

TL;DR: Formal disclosure confirms advisor/fund relationships and an explicit disclaimer of beneficial ownership and group membership.

The statement provides clear governance disclosures: Logos Global acts as an investment adviser to funds, Logos Global GP and Logos GP serve as general partners, and Dr. William is identified as a control person of those entities. The filing’s joint submission with explicit disclaimers and the certification language indicates a compliance-focused document rather than a strategic ownership disclosure. Signatures dated 08/13/2025 complete the filing.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Logos Global Management LP
Signature:/s/ Arsani William
Name/Title:Managing Partner
Date:08/13/2025
Logos Global Management GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:08/13/2025
Logos Global Master Fund LP
Signature:/s/ Arsani William
Name/Title:Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP
Date:08/13/2025
Logos GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:08/13/2025
Arsani William
Signature:/s/ Arsani William
Name/Title:Reporting person
Date:08/13/2025

FAQ

What does the Schedule 13G/A filed for Annexon (ANNX) report?

The filing reports that Logos Global entities and Arsani William beneficially own 0 shares of Annexon common stock, representing 0% of the class.

Who are the reporting persons listed on the Annexon (ANNX) Schedule 13G/A?

The reporting persons are Logos Global Management LP; Logos Global Management GP LLC; Logos Global Master Fund LP; Logos GP LLC; and Arsani William.

When is the event date and when was the Schedule 13G/A signed?

Date of event requiring the filing is 06/30/2025 and the filing is signed by Arsani William on 08/13/2025.

Does the filing indicate the reporters are acting as a group for Annexon (ANNX)?

No. The reporting persons state they are filing jointly but expressly disclaim membership in a group.

Where is the principal business address of the filer listed in the Schedule 13G/A?

Filer address provided is One Letterman Drive, Building C, Suite C3-350, San Francisco, California 94129.
Annexon, Inc.

NASDAQ:ANNX

ANNX Rankings

ANNX Latest News

ANNX Latest SEC Filings

ANNX Stock Data

809.37M
134.16M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRISBANE